The invention is a process for purifying TAFIa from a serum sample in the presence of a reversible inhibitor of TAFIa. The invention is also a method of measuring the activity of TAFIa in the presence of a reversible inhibitor.

 
Web www.patentalert.com

> Pharmaceutical composition inducing cancer cell differentiation and the use for treatment and prevention of cancer thereof
~ 00324